688046 logo

GemPharmatech XSSC:688046 Stock Report

Last Price

CN¥11.02

Market Cap

CN¥4.5b

7D

-1.6%

1Y

-33.9%

Updated

11 Sep, 2024

Data

Company Financials +

GemPharmatech Co., Ltd.

XSSC:688046 Stock Report

Market Cap: CN¥4.5b

688046 Stock Overview

A contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide.

688046 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth5/6
Past Performance1/6
Financial Health6/6
Dividends2/6

GemPharmatech Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GemPharmatech
Historical stock prices
Current Share PriceCN¥11.02
52 Week HighCN¥22.45
52 Week LowCN¥9.08
Beta0.19
11 Month Change1.38%
3 Month Change-7.86%
1 Year Change-33.85%
33 Year Changen/a
5 Year Changen/a
Change since IPO-46.09%

Recent News & Updates

Recent updates

Shareholder Returns

688046CN Life SciencesCN Market
7D-1.6%-1.0%-2.0%
1Y-33.9%-42.7%-21.2%

Return vs Industry: 688046 exceeded the CN Life Sciences industry which returned -42.7% over the past year.

Return vs Market: 688046 underperformed the CN Market which returned -21.2% over the past year.

Price Volatility

Is 688046's price volatile compared to industry and market?
688046 volatility
688046 Average Weekly Movement6.6%
Life Sciences Industry Average Movement6.2%
Market Average Movement5.4%
10% most volatile stocks in CN Market8.6%
10% least volatile stocks in CN Market3.6%

Stable Share Price: 688046 has not had significant price volatility in the past 3 months.

Volatility Over Time: 688046's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20171,506Jing Zhaowww.gempharmatech.com

GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services.

GemPharmatech Co., Ltd. Fundamentals Summary

How do GemPharmatech's earnings and revenue compare to its market cap?
688046 fundamental statistics
Market capCN¥4.52b
Earnings (TTM)CN¥157.68m
Revenue (TTM)CN¥666.71m

30.1x

P/E Ratio

7.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688046 income statement (TTM)
RevenueCN¥666.71m
Cost of RevenueCN¥230.08m
Gross ProfitCN¥436.62m
Other ExpensesCN¥278.94m
EarningsCN¥157.68m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.38
Gross Margin65.49%
Net Profit Margin23.65%
Debt/Equity Ratio5.1%

How did 688046 perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

41%

Payout Ratio